| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1043919624 |
| P356 | DOI | 10.2165/00003495-199039030-00004 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.2165/00003495-199039030-00004 |
| P698 | PubMed publication ID | 2184006 |
| P2093 | author name string | Dart AM | |
| P2860 | cites work | Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent | Q24613185 |
| WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Report of the Committee of Principal Investigators | Q28261597 | ||
| Effect of pectin on serum cholesterol, fecal bile acids and biliary lipids in normolipidemic and hyperlipidemic individuals | Q28332520 | ||
| Coronary heart disease — The global picture | Q33922147 | ||
| Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin | Q34190482 | ||
| LOWERING OF CHOLESTEROL ABSORPTION AND BLOOD LEVELS BY ILEAL EXCLUSION. EXPERIMENTAL BASIS AND PRELIMINARY CLINICAL REPORT. | Q34257058 | ||
| Heart-liver transplantation in a patient with familial hypercholesterolaemia | Q34291627 | ||
| Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros | Q34360883 | ||
| Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange | Q34492190 | ||
| Probucol inhibits oxidative modification of low density lipoprotein | Q34522551 | ||
| Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study | Q34551104 | ||
| Prognosis after myocardial infarction: results of 15 year follow up | Q34555754 | ||
| Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease | Q34687253 | ||
| Classification of hyperlipidaemias and hyperlipoproteinaemias | Q36720342 | ||
| Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein receptor activity and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in blood | Q36995621 | ||
| The role of dietary polyunsaturated fat in lowering blood cholesterol in man | Q37742389 | ||
| Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia | Q38672462 | ||
| The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs | Q39460803 | ||
| Plasma exchange for hypercholesterolaemia | Q72471639 | ||
| Towards an improved lipid-lowering diet: additive effects of changes in nutrient intake | Q72511967 | ||
| Prostacyclin production augmented in the short term by nicotinic acid | Q72560299 | ||
| Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. A randomised controlled trial | Q72560556 | ||
| Ingestion of egg raises plasma low density lipoproteins in free-living subjects | Q72574044 | ||
| Triglyceride-lowering effect of marine polyunsaturates in patients with hypertriglyceridemia | Q93605529 | ||
| Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia | Q39540986 | ||
| Bezafibrate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hyperlipidaemia | Q39662621 | ||
| The effects of antihypertensive drugs on serum lipids and lipoproteins, I. Diuretics | Q39743407 | ||
| The influence of exercise training on plasma lipids and lipoproteins in health and disease. | Q39747210 | ||
| The Dietary Treatment of Hyperlipidemia: Rationale, Technique and Efficacy | Q40128912 | ||
| Cholestyramine and ileal by-pass in the treatment of familial hypercholesterolaemia | Q40134559 | ||
| Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia | Q40173986 | ||
| The evidence for the antiatherogenicity of high density lipoprotein in man | Q40226091 | ||
| Laboratory test results as predictors of recurrent coronary artery stenosis following angioplasty | Q41356744 | ||
| Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. | Q41900355 | ||
| Cholesterol tracking; prediction over time of serum cholesterol in Evans County. Ga. | Q44607503 | ||
| The triglyceride issue: a view from Framingham | Q44822390 | ||
| Effects of Maxepa on serum lipids in hypercholesterolaemic subjects. | Q45910285 | ||
| Hypertriglyceridemia Associated with Deficiency of Apolipoprotein C-II | Q46930868 | ||
| Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial. | Q49173418 | ||
| The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins. | Q51651570 | ||
| Risk factors for myocardial infarction in the Stockholm prospective study. A 14-year follow-up focussing on the role of plasma triglycerides and cholesterol | Q51663235 | ||
| Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. | Q51679983 | ||
| Comparison of actions of soy protein and casein on metabolism of plasma lipoproteins and cholesterol in humans. | Q53833349 | ||
| A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators | Q66890716 | ||
| Clofibrate and niacin in coronary heart disease | Q66891546 | ||
| The effect of treatment with clofibrate on hepatic triglyceride and lipoprotein lipase activities of post heparin plasma in male patients with hyperlipoproteinemia | Q67598310 | ||
| Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation | Q68123693 | ||
| Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts | Q68156084 | ||
| Effects of dietary supplementation with n-6 and n-3 long-chain polyunsaturated fatty acids on serum lipoproteins and platelet function in hypertriglyceridaemic patients | Q68914387 | ||
| Randomised trial of fish oil for prevention of restenosis after coronary angioplasty | Q69371734 | ||
| Paradoxical elevation of LDL apoprotein B levels in hypertriglyceridaemic patients and normal subjects ingesting fish oil | Q69609381 | ||
| Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society | Q69749258 | ||
| Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids | Q69836103 | ||
| Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia | Q69850395 | ||
| Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia | Q69888923 | ||
| Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol | Q70020772 | ||
| The inverse relation between fish consumption and 20-year mortality from coronary heart disease | Q70093671 | ||
| The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery | Q70227394 | ||
| The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease | Q70309305 | ||
| The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering | Q70309308 | ||
| The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions. A controlled study | Q70327266 | ||
| Effects of two low-dose oral contraceptives on serum lipids and lipoproteins: differential changes in high-density lipoprotein subclasses | Q70425410 | ||
| Effect of short-term treatment with bezafibrate and fenofibrate on biliary lipid metabolism in patients with hyperlipoproteinaemia | Q70484522 | ||
| Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man | Q70731976 | ||
| Serum triglycerides, to be or not to be a risk factor for ischaemic heart disease? | Q70864185 | ||
| Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia | Q70882823 | ||
| Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism | Q71166953 | ||
| Effects of probucol on low density lipoprotein removal and high density lipoprotein synthesis | Q71505107 | ||
| High density lipoproteins and atherosclerosis | Q72143013 | ||
| W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators | Q72429087 | ||
| Multicentre study of soybean protein diet for outpatient hyper-cholesterolaemic patients | Q72432465 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 374-387 | |
| P577 | publication date | 1990-03-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Managing elevated blood lipid concentrations. Who, when and how? | |
| P478 | volume | 39 |
| Q33646070 | Clinical positioning of HMG-CoA reductase inhibitors in lipid management protocols |
| Q71857132 | Long-term efficacy with fluvastatin as monotherapy and combined with cholestyramine (a 156-week multicenter study). French-Dutch Fluvastatin Study Group |
| Q33560221 | Simvastatin: a pharmacoeconomic evaluation of its cost-effectiveness in hypercholesterolaemia and prevention of coronary heart disease |
Search more.